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Oxytocin is frequently used worldwide. Some of its adverse
effects are well known, but bronchospasm and laryngeal
stridor as anaphylactoid reactions have not yet been
reported.
Oxytocin is a synthetically prepared hormone that stimulates
contractions of uterine smooth muscle and it is used for
induction and augmentation of labor as well as in abortions.
Adverse effects reported with oxytocin include reflex
tachycardia, hypotension, electrocardiographic changes,
increased cardiac output, myocardial infarction, alteration in
fetal heart rate, seizures, headache, memory impairment,
cerebrospinal bleeding, hyponatremia, syndrome of
inappropriate antidiuretic hormone secretion, nausea and
vomiting, uterine rupture, neonatal hyperbilirubinemia, and
anaphylaxis [1]. To our knowledge, bronchospasm and
laryngeal stridor occur very rarely in oxytocin anaphylaxis.
A 41-year-old woman was admitted to our intensive care unit
after having a septic abortion in the 18th week of pregnancy.
This was her second gestation (the first culminating in a
cesarean section). After abortion she presented with septic
shock, oligoanuria, consumption coagulopathy, and
respiratory insufficiency.
She was first treated intravenously with crystalloids, colloids,
inotropics, furosemide perfusion, empirical antibiotics (i.e.
cefotaxime, metronidazol, and doxycycline), and frozen fresh
plasma. She was anticoagulated with low-molecular-weight
heparin. She also received an intravenous infusion of oxytocin at
40mU/min. Just after infusion, she showed signs of tachypnea,
bronchospasm, and laryngeal stridor. We immediately started
treatment with β2 agonist drugs. Thirty minutes later the patient
showed slight improvement, but symptoms only disappeared
when oxytocin was withdrawn. The patient’s condition improved
rapidly and recovery was uneventful. She had had no previous
allergic reactions or asthma.
Anaphylactoid reactions to oxytocin have been described in
the literature [2]. Some of the clinical presentations of
oxytocin anaphylactoid reactions described include patchy
erythema, hypotension, bronchospasm, and reduced oxygen
saturation [3,4]. A case of life-threatening respiratory distress
following the use of oxytocin during cesarean delivery was
reported in 1994; the authors of that report also suggested
that this was an anaphylactoid reaction to synthetic oxytocin
[5]. In the case described here, the close temporal
relationship between oxytocin administration and
bronchospasm and laryngeal stridor, and the rapid abatement
of symptoms following oxytocin withdrawal suggest that the
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